Results 101 to 110 of about 1,502,489 (240)

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies

Drug Design, Development and Therapy, 2023
Yusuf Mushtaq,1,* Maryam M Mushtaq,2,* Zisis Gatzioufas,3 Matteo Ripa,4 Lorenzo Motta,5 Georgios D Panos1 1Department of Ophthalmology, Queen’s Medical Centre, Nottingham University Hospitals NHS Trust & School of Medicine, University of ...
Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD   +5 more
doaj  

Lasker Foundation: 2014 Annual Report [PDF]

, 2015
Lasker Foundation 2014 Annual Report, highlighting this years achievements which include, the leadership of the Foundation, current scientific advances and the importance of sustained support for biomedical ...

core  

The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion

Oftalʹmologiâ, 2019
Aim: To analyze the effectiveness of intravitreal injection of an anti-VEGF agent (ranibizumab) and an dexametazon implant for the intravitreal injection, in real clinical life. Patients and Methods.
M. V. Budzinskaya, A. V. Shelankova, A. A. Plukhova, N. M. Nuriyeva, A. S. Sorokin   +4 more
doaj   +1 more source

Dexamethasone Implant (Ozurdex) in a Case with Unilateral Simultaneous Central Retinal Vein and Branch Retinal Artery Occlusion

Case Reports in Ophthalmology, 2015
Simultaneous branch retinal artery and vein occlusion is a rare condition that may cause severe visual loss, and its treatment is often unrewarding. Herein, we report a case with simultaneous central retinal vein and branch retinal artery occlusion; it ...
Taylan Ozturk, Omer Takes, A. Osman Saatci   +2 more
doaj   +1 more source

Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report

Türk Oftalmoloji Dergisi, 2019
The intravitreal dexamethasone implant Ozurdex is indicated for the treatment of macular edema due to diabetes and branch retinal vein occlusion. While the most common ocular side effects are elevated intraocular pressure and cataract formation, rare ...
Cansu Ekinci, Alp Kayıran, Hakan Özdemir   +2 more
doaj   +1 more source

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

Case Reports in Ophthalmology, 2012
Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation.
Sebastián Martínez-Castillo, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Cristina Marín-Lambíes, Manuel Díaz-Llopis   +4 more
doaj   +1 more source

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Case Reports in Ophthalmological Medicine, 2017
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion.
Erdem Eris, Gurkan Erdogan, Irfan Perente, Gokhan Demir, Burcin Kepez Yildiz, Ebru Demet Aygit   +5 more
doaj   +1 more source

Vitreous implant for retinal detachment.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1998
Click on the link to view.
openaire   +2 more sources

Retinal Implants [PDF]

JAMA Ophthalmology, 2014
Alice T, Chuang, Allison J, Chen, Jimmy J, Chan, Curtis E, Margo, Paul B, Greenberg   +4 more
openaire   +2 more sources

Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

Clinical Ophthalmology, 2011
Rocío Herrero-Vanrell1, Jose Augusto Cardillo2, Baruch D Kuppermann31Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Complutense University, Madrid, Spain; 2Hospital de Olhos de Araraquara, Araraquara, São ...
Rocío Herrero-Vanrell, Jose Augusto Cardillo, Baruch D Kuppermann   +1 more
doaj